Life Science Archives - Level39

PDS Biotech Enrolls First Stage of Checkpoint Inhibitor Naïve Patient Arm of Phase 2 Clinical Trial in Advanced HPV-16 Positive Head and Neck Cancer

Life Science
Technology

London, UK – 05 October 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group,  announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has announced the completion of enrollment for the first stage …

Read more

NetScientific Plc Announce an Initial £1m Investment in Martlet Capital Limited

Life Science
Technology

London, UK – 16 September 2021 – NetScientific plc (AIM: NSCI), an active holding company in life sciences and sustainability technology investment, is pleased to announce an initial £1m investment in Martlet Capital Limited (“Martlet Capital”), which intends to acquire …

Read more